Market cap data unavailable. We couldn't positively verify this ticker's market cap is under $500M. Verify independently before trading.
The Greater Cannabis Company, Inc.
- Market Cap
- Unavailable
- Price
- $0.28
- % Change (Daily % change from the live per-ticker quote feed.)
- -16.39%
- Volume
- 2.8K
About
The Greater Cannabis Company, Inc. engages in the development and commercialization of cannabinoid therapeutics. It offers an oral transmucosal patch platform, which provides loaded actives absorbed by the buccal mucosa into the body. The company has a license agreement with Shaare Zedek Scientific Ltd. that focuses on treatment of autism, schizophrenia, Parkinson’s disease, Alzheimer’s disease, and other neuropsychiatric disorders. The company was founded in 2014 and is based in Baltimore, Maryland.
Quick stats
Shares outstanding—
Computed float585
Float / sharesUnknown
Key info
SectorHealthcare
IndustryMedical - Pharmaceuticals
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001695473
Websitehttps://www.gcanrx.com
AI Summary
AI-generated1/2
standardbullishticker change
Trafalgar International Launches U.S. Public Company Platform for Financial Services and Strategic Investment
Trafalgar International has completed a legal name change from The Greater Cannabis Company, Inc. in the State of Florida and submitted a corporate action to FINRA to update its trading symbol and CUSIP.
The company is under new ownership after Trafalgar Asset Management LLC acquired 96.62% of total voting power and is repositioning as a publicly traded platform for financial services and fintech.
All outstanding indebtedness has been cancelled, and management clarified that legacy cannabis-related intellectual property is not central to the new strategy.
Red flags
- Control acquired via preferred stock purchase representing 96.62% of voting power
- Company pivoting from legacy cannabis business to financial services with execution risk